The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01 in Phase I.

NCT06710561 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Carcinoma

Interventions

DRUG: SPN01 for Injection
OTHER: Placebo
DRUG: SPN01 for Injection

Sponsor

Beijing SonoPhotoNano Medical Technology Co., Ltd.